ID
Ideaya Bio
IDYA·NASDAQS San Francisco CAFounded 2015190 employees
Mid CapbiotechPublicOncology
Platform: Synth Lethality
Market Cap
$4B
All Drugs
3
Clinical Trials
6
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (IDYA)
Loading IDYA stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Semamavacamten | IDY-7421 | Phase 1/2 | 2 | AuroraA | FabryEpilepsy | ||
| IDY-3466 | IDY-3466 | NDA/BLA | 2 | Nectin-4 | IgANHCC | ||
| Adagrarapivir | IDY-4629 | Phase 1/2 | 2 | IL-17A | CML |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (6)